Literature DB >> 8932288

Sequential cytokine expression in renal allografts in rats immunosuppressed with maintenance cyclosporine or mycophenolate mofetil.

K C Nadeau1, H Azuma, N L Tilney.   

Abstract

Although the immunosuppressive agents used clinically modulate acute rejection of organ allografts, their ability to prevent chronic rejection has been less clear. To ascertain the effects of prolonged maintenance treatment with cyclosporine (CsA) and mycophenolate mofetil, we examined sequential patterns of cytokine regulation by reverse transcriptase polymerase chain reaction in long-surviving renal allografts in treated recipients. In renal allografts in animals on long-term CsA therapy, there is important up-regulation of transforming growth factor-beta, Hsp70, and endothelin as compared with control animals. Conversely, interleukin-2 receptor, interferon-gamma, and tumor necrosis factor-alpha in kidney grafts in this group were expressed at lower levels compared with those noted in chronically rejecting grafts in control animals that had received only CsA for 10 days after transplantation. Morphologically, the long-term CsA-treated kidneys had more extensive arterial obliterative changes and glomerulosclerosis after 24 weeks than control organs; these changes can presumably be attributed to the nephrotoxic effects of this drug combined with the progressive changes of chronic rejection. In contrast, mycophenolate mofetil inhibited the production of all lymphocyte and macrophage-derived cytokines throughout the entire follow-up period. Allograft kidneys in these latter recipients showed no late morphological abnormalities. This agent may be important clinically in preventing chronic rejection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8932288     DOI: 10.1097/00007890-199611150-00034

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Beneficial effect of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil on survival and severity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr/lpr mice.

Authors:  C A Jonsson; L Svensson; H Carlsten
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

2.  Mycophenolic acid differentially impacts B cell function depending on the stage of differentiation.

Authors:  Jodi L Karnell; Fredrick G Karnell; Geoffrey L Stephens; Bhargavi Rajan; Chris Morehouse; Ying Li; Bonnie Swerdlow; Mildred Wilson; Raphaela Goldbach-Mansky; Christopher Groves; Anthony J Coyle; Ronald Herbst; Rachel Ettinger
Journal:  J Immunol       Date:  2011-08-26       Impact factor: 5.422

Review 3.  Mechanisms involved in antibody- and complement-mediated allograft rejection.

Authors:  Barbara A Wasowska
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

4.  Brain dead donor kidneys are immunologically active: is intervention justified?

Authors:  G Vergoulas; P Boura; G Efstathiadis
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

5.  Comparison of mycophenolate mofetil and azathioprine in obstructive nephropathy.

Authors:  Aysun K Bayazit; Yildirim Bayazit; Aytul Noyan; Gulfiliz Gonlusen; Ali Anarat
Journal:  Pediatr Nephrol       Date:  2003-01-10       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.